We are live on
!
Find out more
FAM
Fred Alger Management Portfolio holdings
AUM
$22.8B
1-Year Est. Return
64.63%
This Fund
S&P 500
This Quarter
Est. Return
+15.81%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$19.6B
AUM Growth
+$879M
(+4.7%)
Cap. Flow
-$1.18B
Cap. Flow
% of AUM
-6.05%
Top 10 Holdings %
Top 10 Hldgs %
34.09%
Holding
589
New
74
Increased
137
Reduced
233
Closed
78
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$96.2M |
| 2 |
DraftKings
DKNG
|
+$81.7M |
| 3 |
GE HealthCare
GEHC
|
+$81.1M |
| 4 |
GFL Environmental
GFL
|
+$77M |
| 5 |
Vaxcyte
PCVX
|
+$72.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$187M |
| 2 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
+$143M |
| 3 |
AbbVie
ABBV
|
+$112M |
| 4 |
Walt Disney
DIS
|
+$99.6M |
| 5 |
HSKA
Heska Corp
HSKA
|
+$80.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.16% |
| 2 | Healthcare | 20.31% |
| 3 | Consumer Discretionary | 12.43% |
| 4 | Industrials | 10.17% |
| 5 | Communication Services | 7.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Xponential Fitness
XPOF
$282M
| $6.35M | 0.03% |
+367,975
| New | +$10.4M |
|
227
WillScot Mobile Mini Holdings
WSC
$4.66B
| $6.08M | 0.03% |
127,291
-25,291
| -17% | -$1.13M |
|
228
Universal Display
OLED
$3.85B
| $6.03M | 0.03% |
41,837
-6,002
| -13% | -$860K |
|
229
Tenet Healthcare
THC
$22.6B
| $6.02M | 0.03% |
74,007
+7,311
| +11% | +$520K |
|
230
Arrowhead Research
ARWR
$12.1B
| $5.96M | 0.03% |
+167,055
| New | +$5.76M |
|
231
Ares Management
ARES
$28.8B
| $5.91M | 0.03% |
+61,299
| New | +$5.3M |
|
232
Air Products & Chemicals
APD
$65.2B
| $5.9M | 0.03% |
19,685
+237
| +1% | +$67.5K |
|
233
Mettler-Toledo International
MTD
$28.1B
| $5.86M | 0.03% |
4,466
+139
| +3% | +$195K |
|
|
SPLK
234
DELISTED
Splunk Inc
SPLK
| $5.85M | 0.03% |
55,159
-23,500
| -30% | -$2.23M |
|
235
Alger 35 ETF
ATFV
$203M
| $5.79M | 0.03% |
369,139
-1,377
| -0.4% | -$20.1K |
|
236
Blackrock
BLK
$170B
| $5.79M | 0.03% |
8,375
| – | – |
|
237
ExxonMobil
XOM
$634B
| $5.71M | 0.03% |
53,226
-9
| -0% | -$982 |
|
238
Nu Holdings
NU
$70.9B
| $5.67M | 0.03% |
718,845
+21,345
| +3% | +$131K |
|
239
Illumina
ILMN
$29.2B
| $5.65M | 0.03% |
30,980
-5,003
| -14% | -$1.01M |
|
240
Celldex Therapeutics
CLDX
$2.79B
| $5.61M | 0.03% |
165,317
-198,956
| -55% | -$6.71M |
|
|
KRTX
241
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $5.58M | 0.03% |
25,712
-656
| -2% | -$141K |
|
|
MORF
242
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $5.56M | 0.03% |
96,952
-16,335
| -14% | -$853K |
|
243
Mercury Systems
MRCY
$5.97B
| $5.46M | 0.03% |
157,917
-1,187,416
| -88% | -$50.7M |
|
244
Axos Financial
AX
$5.64B
| $5.44M | 0.03% |
137,918
-6,777
| -5% | -$263K |
|
245
Tandem Diabetes Care
TNDM
$1.22B
| $5.29M | 0.03% |
215,640
-8,768
| -4% | -$282K |
|
246
Latham Group
SWIM
$673M
| $5.29M | 0.03% |
1,425,777
-17,933
| -1% | -$54.8K |
|
247
Qualcomm
QCOM
$172B
| $5.26M | 0.03% |
44,158
| – | – |
|
248
Cheesecake Factory
CAKE
$4.42B
| $5.22M | 0.03% |
151,002
-3,791
| -2% | -$126K |
|
249
Cigna
CI
$79.6B
| $5.2M | 0.03% |
18,522
+18,252
| +6,760% | +$4.75M |
|
250
NVR
NVR
$17.3B
| $5.04M | 0.03% |
794
-15
| -2% | -$87.3K |
|
Similar funds
CAM
BA
AM
SAM
CHP
Fred Alger Management's Q2 2023 Portfolio in Review
As of Q2 2023, Fred Alger Management held 589 positions worth $19.6B, up 4.7% from $18.7B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Fred Alger Management withdrew a net $1.18B in Q2 2023, closing 78 positions and reducing 233 holdings. Its most notable exit was Prometheus Biosciences, Inc. Common Stock, an estimated $143M position sold in full.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Fred Alger Management opened a new position in DraftKings worth $94.2M.
- Fred Alger Management's largest Q2 2023 buy was DraftKings: 3,544,411 shares worth $94.2M.
- Fred Alger Management added most to Meta Platforms (Facebook) in Q2 2023, an estimated $96.2M increase.
- Fred Alger Management's biggest Q2 2023 reduction was Intuit, cutting an estimated $187M.
- Fred Alger Management fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $143M.
- Fred Alger Management's ten largest holdings make up 34% of its $19.6B portfolio in Q2 2023.
- Fred Alger Management opened 74 new positions and closed 78 in Q2 2023.
- Fred Alger Management's portfolio value rose 4.7% quarter-over-quarter to $19.6B.
Based on Fred Alger Management's 13F filing for Q2 2023, filed 14 Aug 2023.